Download MendeleyThe Plasmodium falciparum NCR1 transporter is an antimalarial target that exports cholesterol from the parasite's plasma membrane.
Zhang, Z., Lyu, M., Han, X., Bandara, S., Cui, M., Istvan, E.S., Geng, X., Tringides, M.L., Gregor, W.D., Miyagi, M., Oberstaller, J., Adams, J.H., Zhang, Y., Nieman, M.T., von Lintig, J., Goldberg, D.E., Yu, E.W.(2024) Sci Adv 10: eadq6651-eadq6651
- PubMed: 39693420
- DOI: https://doi.org/10.1126/sciadv.adq6651
- Primary Citation of Related Structures:
8V0G, 8V12, 8V1G - PubMed Abstract:
Malaria, a devastating parasitic infection, is the leading cause of death in many developing countries. Unfortunately, the most deadliest causative agent of malaria, Plasmodium falciparum , has developed resistance to nearly all currently available antimalarial drugs. The P. falciparum Niemann-Pick type C1-related (PfNCR1) transporter has been identified as a druggable target, but its structure and detailed molecular mechanism are not yet available. Here, we present three structures of PfNCR1 with and without the functional inhibitor MMV009108 at resolutions between 2.98 and 3.81 Å using single-particle cryo-electron microscopy (cryo-EM), suggesting that PfNCR1 binds cholesterol and forms a cholesterol transport tunnel to modulate the composition of the parasite plasma membrane. Cholesterol efflux assays show that PfNCR1 is an exporter capable of extruding cholesterol from the membrane. Additionally, the inhibition mechanism of MMV009108 appears to be due to a direct blockage of PfNCR1, preventing this transporter from shuttling cholesterol.
- Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Organizational Affiliation:
